MedTrace Logo

Stroke Prevention and Rhythm Interventions in Atrial Fibrillation

NCT01733160 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2499

Last updated 2017-10-27

No results posted yet for this study

Summary

This observational registry will characterize contemporary stroke prevention in Canadian adults with atrial fibrillation, and provide clarity in understanding physician preferences for the various oral anticoagulants available in the Canadian marketplace. This study will determine the patient profiles of those selected for the various therapies available in Canada and provide an understanding of the factors involved in drug selection and management.

Conditions

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Canadian Collaborative Research Network

    lead OTHER

Principal Investigators

  • Milan K Gupta, MD · Canadian Collaborative Research Network

  • Andrew Ha, MD · Canadian Collaborative Research Network

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2017-08-15
Completion
2017-08-15

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01733160 on ClinicalTrials.gov